Table 3

Crude estimates of mortality, length of stay, and organ dysfunction stratified by study period


Period I
(n = 2,366)
1 Mar 01 to 28 Feb 02
Period II
(n = 3,322)
1 Mar 02 to 30 Jun 03
Period III
(n = 4,786)
1 Jul 03 to 28 Feb 05
P valuea

ICU mortality, n (%)
214 (9.04)
358 (10.78)
465 (9.75)
0.086
OR (95% CI) of ICU mortality
1.00
1.21 (1.01, 1.46)
1.09 (0.92, 1.29)

Hospital mortality, n (%)
334 (14.12)
522 (15.71)
686 (14.39)
0.157
OR (95% CI) of hospital mortality
1.00
1.13 (0.97, 1.32)
1.02 (0.88, 1.17)

Patients in ICU <3 days
n = 1,296
n = 1,829
n = 2,678

ICU mortality in patients in ICU <3 days, n (%)
76 (5.86)
128 (7.0)
181 (6.76)
0.428
Hospital mortality in patients in ICU <3 days, n (%)
122/1,174 (9.4)
203/1,829 (11.1)
283/2,678 (10.6)
0.310
Hospital mortality in patients with hypoglycemia <40 mg/dL, n (%)
9/24 (38)
23/53 (43)
41/103 (40)
0.863
Average SOFA score, mean ± SDb
1.65 (2.00)
1.77 (2.09)
1.62 (1.98)
<0.01
Maximum SOFA score, mean ± SDb
2.82 (2.85)
2.96 (2.99)
2.74 (2.84)
0.004

aAnalysis of variance or chi-square comparing the three study periods; period I is used as reference. bScores for the Sequential Organ Failure Assessment (SOFA) can range from 0 to 24, with higher scores indicating a higher risk of death. CI, confidence interval; ICU, intensive care unit; OR, odds ratio; SD, standard deviation.

Treggiari et al. Critical Care 2008 12:R29   doi:10.1186/cc6807